Clinical Trial Update: Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor [NA]

View source ↗

Summary

This completed clinical trial update evaluates predictive immunological parameters of molecular complete remission in chronic myeloid leukemia in chronic phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Chronic Leukemia | NA | Status: COMPLETED